Senhwa Biosciences identifies and develops innovative therapies that have the potential to fundamentally change the way patients are treated. Our central philosophy is to unearth validated targets or therapies that could significantly improve treatment, but have not yet been properly exploited. As a value-added development company, Senhwa aims to take innovative therapies that could impact the current standard of care and drive them through to clinical proof-of-concept.
Morningside Group is a private investment group founded in 1986 by the Chan family of Hong Kong.
China Investment & Development was added to CrunchBase in 2013
H&Q Asia Pacific (H&QAP) is a leading Asian private equity firm. Originally founded by...
9191 Towne Centre Drive
San Diego, CA 92122